Pacific Northwest National Laboratory (PNNL), operated by Battelle Memorial Institute under contract to the U.S. Department of Energy, solicits interest from companies interested in obtaining license rights to commercialize, manufacture and market the following technology.  License rights may be issued on an exclusive or nonexclusive basis and may include specific fields of use.  PNNL may also be available to licensee(s) to assist in further research and development of the technology under a SPP agreement, ACT agreement, or CRADA agreement.

THE TECHNOLOGY:  PNNL conducts research in systems and methods for automation of high-purity radioisotope production and has developed a fluidic platform capable of generating and purifying ²¹²Pb. The ²¹²Pb product can be in a label-ready solution and there is not a need to evaporate an acid to dryness nor to dissolve residues in a buffer solution. The platform can be automated to reduce worker dose. Furthermore, the system can be made sterile.

For all inquiries, please reference Battelle IPIDs 31465-E and 31343-E

NOTE:  THIS IS NOT A PROCUREMENT.  Any company interested in licensing this technology must respond with a letter of interest (may be submitted by e-mail) no later than thirty (30) days from the publication date of this Notice summarizing the company’s business and technical expertise and motivation for pursuing this opportunity.  Companies deemed appropriate will be provided with further information on the technology.  Such information may require an executed Nondisclosure Agreement.  Respondents wishing to enter into negotiations for a commercial license will be required to submit a business plan for the commercialization of the technology prior to licensee(s) selection and negotiations.  Please send letters of interest to the attention of the POC identified within this Notice, referencing Battelle IPIDs 31465-E and 31343-E.